Table: begin end state 1 28 cytoplasmic 29 49 transmembrane 50 54 non-cytoplasmic 55 79 transmembrane 80 90 cytoplasmic 91 111 transmembrane 112 116 non-cytoplasmic 117 139 transmembrane 140 162 cytoplasmic 163 183 transmembrane 184 194 non-cytoplasmic 195 214 transmembrane 215 245 cytoplasmic 246 270 transmembrane 271 283 non-cytoplasmic 284 305 transmembrane 306 313 cytoplasmic 314 335 transmembrane 336 343 non-cytoplasmic 344 368 transmembrane 369 386 cytoplasmic 387 408 transmembrane 409 413 non-cytoplasmic 414 434 transmembrane 435 467 cytoplasmic
Input: >WP_012383191.1 NCBI__GCF_000019845.1:WP_012383191.1 MTTQRADSDVENGAGLKFLVFASSLGTMIEWYDFFLYGSLAVFFSELFYPKDNPVAALLI SVATFATGFAVRPLGAVLFGHLGDRIGRKTTFLITLLLMGGATALIGILPTYASVGLLAP VLLVVLRLIQGLALGGEYGGAATYVAEHAPDGRRGGWTSAIQTMASMGFFVSLAVVLSCR FLLGDAIFASWGWRIPFLLSAVLVMLSLGARLRLAESPIFLQLKAEDRVSKSPVRESFAD PRNRRLMLAVLFGVASGQAVTFYTANFYALYFLQSILKVDFLTSNLVMVLGVLIGMPLFV LFGIWSDKIGRKPLIIAGMAAAVVLLVPIFMVMQSAVGPQGINIWLLAACVFVLVAIAAA VYGPYAAYLVEVFPPQIRYTSLSIPYHIGNGIFGGFLPLIGLSLVAATGNPLAGLIYPIA VCVINVIIGSLYLPETLHTPIDGRTSVEDLADESLPFAAALPPKSAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server